Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
para-toluenesulfonamide (2 trials)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (1 total)